Article Figures & Data
Figures
- Figure 1.
Disease-free survival curve. Disease-free survival curve for patients with colorectal cancer with high long noncoding RNA activated by transforming growth factor-β (lncRNA-ATB) expression and low lncRNA-ATB expression.
- Figure 2.
Comparison of relative levels of long noncoding RNA activated by transforming growth factor-β (lncRNA-ATB) expression between patients with and those without hematogenous metastases after surgery (p=0.001).
Tables
In this issue
A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
Jump to section
Related Articles
Cited By...
- Long Non-Coding RNA-ATB Attenuates the Angiotensin II-Induced Injury of Vascular Endothelial Cell
- Long noncoding RNA FAM3D-AS1 inhibits development of colorectal cancer through NF-{kappa}B signaling pathway
- Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p
- Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis
- Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis